Product Purchase Price. The full price of all Products including applicable shipping, insurance and taxes along with payment for any other items for which Serono owes payment to Bioject shall be paid in U.S. Dollars no later than 45 days after Serono's receipt of Bioject's invoice or on such other terms agreed to in writing by the parties in advance of the obligation for such payments. Bioject shall not issue any invoice prior to performing the service billed or shipping the Products billed.
Product Purchase Price. The parties agree to the following Product Purchase Prices of all products supplied by Celgene to BeiGene regardless of whether for commercial or non-commercial purposes: [...***...]
Product Purchase Price. The purchase price payable by Cadista to Jubilant for each Product shall be ninety percent (90%) of the Net Sales of such Product (the “Product Purchase Price”). At the time of delivery of a shipment of a Product to Cadista, Jubilant shall issue to Cadista an invoice for such shipment which will contain the estimated Product Purchase Price calculated based on the then current Expected Market Price for such Product.
Product Purchase Price. (a) Products Ordered after Specified Date. For Product ordered by Eisai (or any Designated Distributor) on or after the Specified Date (under the Existing Agreement, any Third Party Distributor Agreement or under this Agreement), Eisai shall pay Arena the applicable prices set forth on Exhibit D, subject to the adjustments described below. All orders placed by Designated Distributors prior to the Effective Date will remain subject to the payment provisions of the Third Party Distributor Agreements prior to their being assigned to Eisai, payments for such orders will be made by the Designated Distributors to Arena under the terms of the Third Party Distributor Agreements as in effect prior to the Effective Date, and Eisai will not be obligated to pay for such orders; provided, however, if a Designated Distributor pays Eisai and not Arena for orders placed prior to the Effective Date, Eisai will promptly pay any amounts received to Arena. Commencing January 1, 2018, the prices set forth on Exhibit D will increase annually by […***…]% effective only for Product delivered on or after January 1 of the applicable Calendar Year. All payments of the Product Purchase Price under this Section 11.4(a) will be in Swiss francs.
Product Purchase Price. TEAMM shall pay Arius a purchase price per [*] tablet of Product in amounts set by Arius, with respect to each of the [*] bottle, [*] box, and any other packaging forms in which the Product will be sold, based on Arius’ costs and expenses related to the administration, supply, manufacturing, and packaging of the Product (each, the “Purchase Price” with respect to each packaging form), provided that Arius, at its sole discretion, may adjust such prices from time to time during the term of this Agreement in amounts equal to cost increases from Arius’ manufacturer. Arius currently estimates that the Purchase Price will be between $[*] tablet, excluding costs related to additional requirements or features requested by TEAMM, which costs shall be the sole responsibility of TEAMM. The parties shall enter into a separate supply agreement on commercially reasonable terms governing the final Purchase Prices, packaging requirements, and other details of Arius’ obligations with respect to the delivery of Product to TEAMM, consistent with the terms of this Agreement, prior to Arius’ initial delivery of Product to TEAMM hereunder.
Product Purchase Price. The price to be paid by Client for Commercial Product under this Agreement and the Product set forth in the Prior Agreement is set forth in the price tiers in Exhibit A, subject to Section 5.2 (“Purchase Price”) . For Commercial Product, initially, the Purchase Price will be based upon a full Batch Produced by Baxter. Based upon a mutually-agreed upon strategy, as specified in the Product Master Plan, the Parties agree to transition the Purchase Price for Commercial Product to a price based upon a cost per Unit of Product upon the successful completion of production of the process validation batches. [***] INDICATES CONFIDENTIAL PORTION HAS BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION
Product Purchase Price. The Purchase Price will be fixed for the Initial Term (as hereinafter defined) of this Agreement as specified in Exhibit B. The Purchase Price for Product for each calendar year will be the price specified in Exhibit B corresponding to the annual volume which is the greater of (a) [***] percent ([***]%) of the Annual Forecast or (b) the Annual Obligation for such calendar year. AMYLIN shall pay the Purchase Price as determined above for all Product, including Units accepted by AMYLIN pursuant to Article 7 samples consumed by BAXTER for release testing, samples shipped for AMYLIN release and stability testing, and any retention samples; except as provided for in Article 7. In the event AMYLIN requests a change in scope for Production of Product or Regulatory Authority associated with the Production, BAXTER may adjust the Purchase Price for Product or for a particular Presentation of Product as set forth in a revision to Exhibit B as mutually agreed to by the parties.
Product Purchase Price. (a) The purchase price payable by the Customer for each Product (on a SKU-by-SKU basis) (such price in respect of any given Product being the “Product Purchase Price”) will be determined by the Supplier and set out in the NZGW Price List. Subject to clause 8.2(b), the Supplier reserves the right to change any Product Purchase Price in its sole direction, provided that any such change must comply with the Supplier's then-current Pricing Principles (if any). The Product Purchase Price includes the Supplier's margin, the applicable 'pick and pack' fee (by reference to the relevant distribution centre used by the Supplier to fulfil the Order) and the freight costs associated with the delivery of the Products to the Delivery Location.
Product Purchase Price. The purchase price payable by Licensee for one Unit of Product for both commercial (including samples) and clinical trial use, for Product ordered during the period beginning the Effective Date and ending twelve (12) months from first commercial sale of Product in the Territory, shall be €[*] per Unit of Product. The purchase price for each Unit of Product ordered during the next twenty-four (24) months shall be €[*] per Unit of Product. The purchase price per Unit of Product ordered during the next twenty-four (24) months shall be the lower of €[*] plus the annual average percentage change in the Consumer Price Index for the three-year period prior to the beginning of such period and adjusted thereafter on an annual basis, or the Actual True Cost of Goods for a Unit of Product at that time. Thereafter, the purchase price per Unit of Product shall be the Actual True Cost of Goods.
Product Purchase Price. In accordance with the schedule below, the purchase price of the Product shall be decreased as the cumulative number of units purchased by Handspring increases: CUMULATIVE VOLUME PURCHASED UNIT PRICE --------------------------- ---------- [*] [*] [*] [*] [*] [*] [*] [*] [*] [*] [*] [*]
